The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2016

Filed:

Nov. 15, 2011
Applicants:

Scott Gallichan, Burlington, CA;

Ausra Mancevski, Toronto, CA;

Nathalie Reveneau, Toronto, CA;

Jin Su, Markham, CA;

Francois Dalencon, Lyons, FR;

Jean Haensler, Grezieu-la-Varenne, FR;

Inventors:

Scott Gallichan, Burlington, CA;

Ausra Mancevski, Toronto, CA;

Nathalie Reveneau, Toronto, CA;

Jin Su, Markham, CA;

Francois Dalencon, Lyons, FR;

Jean Haensler, Grezieu-la-Varenne, FR;

Assignees:

Sanofi Pasteur Limited, Toronto, CA;

Sanofi Pasteur S.A., Lyons, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 6/00 (2006.01); A61K 39/39 (2006.01); A61K 38/00 (2006.01); A61K 39/02 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 39/118 (2006.01); A61K 47/44 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/0019 (2013.01); A61K 9/107 (2013.01); A61K 9/1075 (2013.01); A61K 39/118 (2013.01); A61K 47/44 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01);
Abstract

The present invention provides compositions comprising a Chlamydial major outer membrane protein (referenced herein as 'MOMP'), from at least one Chlamydial serovar and an adjuvant, characterized in that the adjuvant comprises the product E6020 having CAS Number 287180-63-6. The composition may further comprise at least one carrier system (e.g., emulsion, mineral particle). The MOMP protein may be derived from any species of(e.g.,, orMoPn). In preferred embodiments, the composition comprises one or more major outer membrane proteins each derived from different serovars of. The invention also provides methods of inducing an immune response to aspecies (e.g.,) in a subject, by administering to the subject a composition of the invention.


Find Patent Forward Citations

Loading…